What questions should a CIO ask before buying healthcare AI?
A hospital CIO (Chief Information Officer) should ask six things before buying healthcare AI: Where does our patient data live and who can access it? Is there a human-review checkpoint and a complete audit trail on every AI output? How does it integrate with our existing HIS/EMR (Hospital Information System / Electronic Medical Record) without a rebuild? What are the data-residency and compliance terms (UU PDP, PDPA, PDPO)? Is this one point tool or a governed platform we can extend? And what is the exit path for our data if we leave? The right answers describe governed healthcare AI, not autonomous AI. AI writes. Doctors decide.
The failure mode in healthcare AI procurement is buying a demo, not an operating model. A slick single-task tool can still leave the CIO owning integration debt, an unclear audit story, and patient data copied somewhere they can't see. The questions above shift the evaluation from 'what can it do' to 'how is it governed, integrated, and accountable' — which is what determines whether it survives a regulator's question and a five-year roadmap.
Concretely: insist on least-privilege access and a per-action audit log; require a human-in-the-loop checkpoint before any AI output enters the record; confirm it adapts to your systems rather than forcing a migration; and prefer a shared, governed platform over a pile of disconnected apps. Micromeet's products (MCU CoPilot, AI Scribe (Voice-to-EMR), Care Loop, Claim Readiness, AI Care Command Center) are built on one governed layer for exactly these reasons. The CIO's job is to buy the governance and the integration, not just the model.
Related questions
Is data residency really a buying criterion?+
How do I tell a point tool from a platform in a sales demo?+
Micromeet — AI for governed healthcare. MCU CoPilot, AI Scribe (Voice-to-EMR), AI Front Desk, Care Loop, Claim Readiness and AI Care Command Center — every output doctor-reviewed. AI writes. Doctors decide. See the public benchmark →